The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDX..L Regulatory News (DX.)

  • There is currently no data for DX.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director Share Purchase - Replacement

18 Sep 2020 11:24

RNS Number : 4568Z
DX (Group) PLC
18 September 2020
 

18 September 2020

AIM: DX.

 

 

DX (GROUP) PLC

 

 ("DX", the "Company" or "the Group")

 

The following amendment has been made to the 'Director Share Purchase' announcement released on 17 September 2020 at 16:31 under RNS No 3520Z.

 

The total number shares acquired by Ronald Series was 210,500 (not 210,000 as previously announced). The average price paid was 18.27p (not 18.26p as previously announced).

 

The full amended text is shown below.

 

 

Director Share Purchase

DX, the provider of delivery solutions, including parcel freight, secure, courier and logistics services, announces that on 17 September 2020, Ronald Series, Executive Chairman, purchased a total of 115,500 ordinary shares of 1 penny each ("Ordinary Shares") at an average price of 17.25 pence per Ordinary Share, and a further 95,000 Ordinary Shares at an average price of 19.5 penny per Ordinary Share.

 

 

Following the above transactions, Ronald Series has a total beneficial holding of 2,345,794 Ordinary Shares (including shares held by his PCAs) representing 0.41% of the Company's issued share capital.

 

Enquiries:

 

DX (Group) plc

www.dxdelivery.com

 

 

Ronald Series, Executive Chairman

T: 020 3178 6378

Lloyd Dunn, Chief Executive Officer

David Mulligan, Chief Financial Officer

(c/o KTZ Communications)

 

 

finnCap (Nominated Advisor and Broker)

T: 020 7220 0500

Matt Goode/Simon Hicks/Kate Washington (Corporate Finance)

Andrew Burdis (Corporate Broking)

 

 

 

Liberum (Joint broker)

T: 020 3100 2000

Robert Morton/Euan Brown/William Hall

 

 

 

KTZ Communications

T: 020 3178 6378

Katie Tzouliadis/Dan Mahoney

 

     

 

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via regulatory news service this inside information is now considered to be in the public domain.

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Ronald Series

2.

Reason for the notification

a)

Position/status:

Executive Chairman

b)

Initial notification/Amendment:

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

DX (Group) Plc

b)

LEI:

213800LA2YGSOFIYIH95

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary Shares of 1p nominal value

GB00BJTCG679

b)

Nature of the transaction:

Purchase of Ordinary Shares

c)

Price(s) and volume(s):

Price(s) pence

Volume(s)

17.25

115,500

19.5

95,000

 

d)

Aggregated information:

· Aggregated volume:

· Price:

 

Average Price pence

Volume(s)

18.27

210,500

 

e)

Date of the transaction:

17 September 2020

f)

Place of the transaction:

London Stock Exchange, AIM (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUWURRRUUKAAR
Date   Source Headline
30th Jan 20247:00 amRNSCancellation - DX (Group) PLC
29th Jan 20242:16 pmRNSForm 8.3 - DX (Group) plc
29th Jan 202410:54 amRNSForm 8.5 (EPT/RI) - DX (Group) plc
29th Jan 202410:29 amRNSScheme Effective
29th Jan 20249:30 amRNSForm 8.5 (EPT/RI)
26th Jan 202412:06 pmRNSForm 8.3 - DX (Group) plc
26th Jan 202410:22 amRNSForm 8.5 (EPT/RI)
26th Jan 20247:00 amRNSRule 2.9 Announcement
25th Jan 20244:02 pmRNSForm 8.3 -DX GROUP PLC Amendment
25th Jan 20242:12 pmRNSForm 8.3 - DX (Group) plc
25th Jan 20241:03 pmRNSPDMR Dealings
25th Jan 202411:51 amRNSResults of Sanction Hearing
25th Jan 202410:14 amRNSForm 8.5 (EPT/RI) - DX (Group) plc
24th Jan 202411:23 amRNSForm 8.5 (EPT/RI)
23rd Jan 20241:27 pmRNSUpdate on financing arrangements
23rd Jan 202410:43 amRNSForm 8.5 (EPT/RI)
22nd Jan 20242:03 pmRNSForm 8.3 - DX GROUP PLC
22nd Jan 202412:36 pmGNWForm 8.3 - DX (Group) Plc
22nd Jan 202411:09 amRNSForm 8.5 (EPT/RI) - DX (Group) plc
22nd Jan 202411:02 amRNSForm 8.5 (EPT/RI)
19th Jan 20243:29 pmRNSForm 8.3 - DX Group Plc
19th Jan 20242:40 pmPRNForm 8.3 - DX (Group) Plc
19th Jan 202412:11 pmRNSForm 8.3 - DX GROUP PLC
19th Jan 202410:44 amRNSForm 8.5 (EPT/RI) - DX (Group) plc
19th Jan 202410:12 amRNSForm 8.3 - DX (Group) Plc
19th Jan 20249:34 amRNSForm 8.5 (EPT/RI)
18th Jan 202412:52 pmRNSForm 8.3 - DX (Group) plc
18th Jan 20249:22 amRNSForm 8.5 (EPT/RI)
17th Jan 20242:35 pmRNSForm 8.3 - DX (Group) plc
17th Jan 202411:15 amRNSForm 8.5 (EPT/RI)
17th Jan 202410:16 amRNSForm 8.5 (EPT/RI) - DX (Group) plc
16th Jan 20241:17 pmRNSForm 8.3 - DX (Group) plc
16th Jan 202411:47 amRNSForm 8.5 (EPT/RI)
15th Jan 202410:53 amRNSForm 8.5 (EPT/RI)
15th Jan 202410:00 amRNSForm 8.5 (EPT/RI) - DX (Group) Plc
12th Jan 20241:26 pmRNSForm 8.3 - DX (Group) plc
12th Jan 202411:28 amRNSForm 8.5 (EPT/RI)
12th Jan 202410:44 amRNSForm 8.5 (EPT/RI) - DX (Group) Plc
11th Jan 202412:01 pmRNSHolding(s) in Company
11th Jan 20249:32 amRNSForm 8.5 (EPT/RI)
10th Jan 20241:46 pmRNSForm 8.3 - DX (Group) plc
10th Jan 202412:46 pmPRNForm 8.3 - DX (Group) Plc
10th Jan 20249:37 amRNSForm 8.5 (EPT/RI)
9th Jan 202412:40 pmRNSResults of Court Meeting and General Meeting
9th Jan 202412:24 pmPRNForm 8.3 - DX (Group) Plc
9th Jan 20249:29 amRNSForm 8.5 (EPT/RI)
8th Jan 20242:08 pmRNSForm 8.3 - DX (Group) plc
8th Jan 20241:37 pmRNSForm 8.3 - DX (Group) plc
8th Jan 20241:18 pmRNSForm 8.3 - DX (Group) Plc
8th Jan 20249:39 amRNSForm 8.5 (EPT/RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.